This page contains affiliate links. We may earn a commission at no extra cost to you.
$249–$299 (device) + electrode replacement cost
The Quell by NeuroMetrix is an FDA-cleared wearable neurostimulation device worn on the upper calf, designed for continuous use during both waking hours and sleep to provide ongoing pain management for chronic pain including peripheral neuropathy. Unlike traditional TENS units that are applied with separate electrodes and require the user to remain stationary, the Quell’s calf-band design allows use during daily activities and sleep. It pairs with a smartphone app that tracks therapy parameters, pain levels, activity, and sleep — building a therapeutic profile over time. Quell operates through the same gate-control TENS mechanism as conventional units, but applies stimulation at the upper calf to recruit the neural pathways that project pain inhibition throughout the lower extremity. For patients with widespread lower extremity neuropathy who cannot target specific areas effectively with electrode-based TENS, the Quell’s wearable, always-on design represents a meaningfully different approach.
How It Works
Quell’s electrode strips deliver electrical stimulation to the tibial nerve territory at the upper calf — a location that, through neural pathway activation, modulates pain processing in the spinal dorsal horn for the entire lower extremity. The stimulation activates afferent nerve fibers that project to the brainstem, triggering descending pain inhibition pathways that reduce pain signal processing throughout the lower body.
This differs from conventional TENS in an important way: conventional TENS applied locally to the foot targets the local gate-control mechanism in the area of stimulation. Quell’s calf placement targets proximal nerve recruitment with descending inhibition effects that extend to regions not under the electrode — potentially providing broader coverage for patients with foot and lower leg pain. The NeuroMetrix therapy engine (the proprietary algorithm controlling stimulation parameters) adapts intensity based on feedback from the Quell app’s motion and sleep sensors.
Wearable Design for Continuous Use
The Quell device is worn in a comfortable textile band just below the knee on the upper calf. The electrode strip attaches inside the band and is the consumable component — replaceable strips (OptiTherapy Electrode Strips) are purchased separately and last approximately 2 weeks of continuous use. The device is worn continuously — during work, walking, household activity, and sleep — unlike portable TENS units that are typically used during seated sessions.
This continuous-use design is the Quell’s primary differentiating advantage for neuropathy management. For patients with constant neuropathic symptoms rather than episodic pain, a device that provides ongoing stimulation rather than 20 to 30 minute treatment windows addresses the symptom profile better. The Quell app tracks therapy parameters and allows intensity adjustment from a smartphone — convenient for patients who may have difficulty manually adjusting a device at the calf while going about daily activities.
App-Based Therapy Tracking
The Quell Health Cloud app provides daily and weekly summaries of therapy usage, pain scores entered by the user, activity metrics, and sleep data. Over time, the app builds a personal therapeutic profile that allows NeuroMetrix’s algorithms to optimize stimulation parameters. Users can log pain scores before and after therapy sessions, creating objective data about their individual treatment response that can be shared with their physician.
For patients who are managing multiple interventions and want to track which provides the most benefit, Quell’s built-in data logging is a useful tool. The sleep tracking functionality is particularly relevant for neuropathy patients — nighttime neuropathic symptoms (burning, electric pain, restless legs) are a major quality-of-life burden, and the Quell’s nighttime mode adjusts stimulation parameters for sleep-appropriate use.
Evidence and FDA Clearance
The Quell has FDA 510(k) clearance for symptomatic relief of chronic intractable pain — a higher regulatory standard than OTC TENS clearance, requiring NeuroMetrix to demonstrate safety and efficacy comparable to a legally marketed predicate device. An internal NeuroMetrix study of Quell users with chronic pain (including peripheral neuropathy) found that 81% of users reported meaningful reduction in pain, and 67% reported improved sleep quality after 60 days of use. An independently published pilot study in patients with painful diabetic neuropathy found significant improvements in pain scores and sleep quality over 6 weeks of Quell use.
The ongoing cost of electrode replacement strips (approximately $30 per 2-week supply) is the primary economic consideration for long-term Quell use — annual electrode cost of $700–$800 is meaningful relative to other neuropathy interventions. Medicare coverage for Quell devices is limited; most use is out-of-pocket.
Pros
- Wearable, hands-free design — usable during daily activities and sleep
- Continuous stimulation for constant neuropathic symptoms rather than episodic treatment windows
- FDA-cleared for chronic pain management
- App-based therapy tracking and pain logging — supports physician communication
- Nighttime mode for sleep — addresses one of the most impactful symptom domains in neuropathy
- Calf-band placement provides lower extremity coverage from a single electrode site
Cons
- High ongoing cost — electrode replacement strips ~$30 per 2 weeks = ~$780/year
- Device purchase price ($249–$299) higher than traditional TENS units
- Limited insurance and Medicare coverage — primarily out-of-pocket
- Electrode strip adhesion and fit varies with calf size and skin condition
- Smartphone required for app-based features and optimization
Frequently Asked Questions
Is Quell better than a regular TENS unit for neuropathy?
For patients with constant, widespread lower extremity neuropathic pain, Quell’s wearable continuous-use design is a meaningful advantage over session-based TENS units. For patients with episodic or localized pain, a conventional TENS unit applied directly to the painful area during a session may be equally or more effective at significantly lower cost. The Quell’s value proposition is best for patients who need all-day and overnight stimulation and have difficulty with conventional electrode-based TENS management.
Can I use Quell if I have a pacemaker?
No — like all TENS devices, Quell is contraindicated with implanted pacemakers, defibrillators, and spinal cord stimulators. The electrical stimulation could interfere with implanted electronic device function. If you have any implanted electronic cardiac or neurological device, do not use Quell without explicit clearance from the physician managing your implanted device.
How long before I feel results from Quell?
Some patients report initial relief within the first few days. The NeuroMetrix clinical data suggests that maximum benefit is typically observed at 4 to 6 weeks of consistent use. The therapy adaptation algorithm also requires several weeks to optimize parameters to your individual neural response. Give a consistent 60-day trial before deciding whether Quell is effective for your specific neuropathy.
Buy on Amazon — $249–$299 (device) + electrode replacement cost